Vanrafia (atrasentan) is a medication used to lower protein levels in the urine in adults with immunoglobulin A nephropathy (IgAN). It works as an endothelin receptor antagonist to help reduce stress on the kidneys. Vanrafia (atrasentan) comes as a tablet that’s taken by mouth once a day. Common side effects include swelling in the arms or legs and low red blood cells.
Vanrafia (atrasentan) is an endothelin receptor antagonist that blocks the effects of endothelin-1. Endothelin-1 is a protein that can decrease blood flow to the kidneys.
People with IgAN have a higher amount of endothelin-1 in the body. This can put stress on the kidneys, lead to kidney damage, and cause protein to leak into the urine.
By blocking the effects of endothelin-1, Vanrafia (atrasentan) can help reduce stress on the kidneys. This can lower the amount of protein that leaks into the urine.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
In a study, people with IgAN who took Vanrafia (atrasentan) for 9 months had a 38% decrease in their urine protein-to-creatinine ratio. This is a measure of how much protein is in the urine. Keep in mind that these people were also taking another kidney medication, such as an angiotensin II receptor blocker (ARB) or an angiotensin-converting enzyme (ACE) inhibitor. The study showed that Vanrafia (atrasentan) works well at lowering protein levels in the urine when added to these medications. But more studies are needed to confirm if this helps slow down worsening kidney function.
A study showed that the amount of protein in the urine can start to decrease within 6 weeks after taking Vanrafia (atrasentan). Protein levels in the urine can remain low for several months. Note that in the study, people with IgAN were taking Vanrafia (atrasentan) with another kidney medication. Your healthcare team can keep track of the protein levels in your urine with a urine test during treatment. You might not feel any different when you have lower protein levels in the urine. So ask your healthcare team if you have more questions about how fast this medication is working for you.
You may need to do a urine test from time to time while taking Vanrafia (atrasentan). This measures the amount of protein in your urine and helps your healthcare team check how well the medication is working. You might also need occasional blood tests to check your liver health. This is because Vanrafia (atrasentan) can sometimes cause liver damage. If your liver isn’t working well, your healthcare team may recommend that you stop taking the medication. Talk to your healthcare team to learn more about these tests and what the results mean for you.
Vanrafia (atrasentan) may cause a small decrease in your blood pressure. In a study, blood pressure went down by 4 mmHg on average after 9 months of treatment. This drop in blood pressure rarely caused symptoms. But let your healthcare team know if you feel dizzy or lightheaded. These could be signs that your blood pressure is low.
It’s not recommended to breastfeed while taking Vanrafia (atrasentan). There’s no data on whether or not the medication gets into breast milk. But if it does, there could be a potential for it to cause harm to your breastfed infant. If you’re breastfeeding, don’t take Vanrafia (atrasentan) until you’ve talked to a healthcare professional about the risks and benefits.
Vanrafia (atrasentan) and Filspari (sparsentan) both help lower protein levels in the urine in adults with IgAN. They’re taken by mouth once a day. But Filspari should be taken before breakfast or dinner, whereas Vanrafia can be taken with or without food. Both can often cause swelling in the arms and legs, but Filspari can also raise potassium levels. Each medication has a risk of liver damage, but how often you need to get your liver health checked is different. For Filspari, you’ll need a blood test to check your liver every 3 months. For Vanrafia, regular liver testing isn’t usually required, but your healthcare team might still recommend it to be safe. Compare the medications and talk to your healthcare team to decide which is best for you.
Vanrafia (atrasentan) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don’t take Vanrafia (atrasentan) if you’re pregnant. This medication hasn’t been studied in people who are pregnant. But animal studies showed that it might cause harm to the baby if taken during pregnancy.
If you can become pregnant, you’ll need to take a pregnancy test before starting Vanrafia (atrasentan). You should also use birth control before and during treatment, and keep using it for 2 weeks after stopping the medication. If you become pregnant, stop taking Vanrafia (atrasentan) as soon as possible and tell your healthcare team right away.
Vanrafia (atrasentan) can cause liver damage. In studies, some people taking the medication had high liver enzyme levels. This can be a sign that there’s a problem with your liver.
Before starting Vanrafia (atrasentan), you’ll need a blood test to check your liver health. People with severe liver problems shouldn’t take this medication.
You may also need blood tests during treatment, especially if you have symptoms of liver damage. Watch for yellowing of your skin or eyes, dark urine, stomach pain, nausea, vomiting, or loss of appetite. You also might feel tired, itchy, or have a fever. If this happens, let your healthcare team know. You may need to stop taking Vanrafia (atrasentan) to prevent liver damage from getting worse.
Vanrafia (atrasentan) can cause fluid to build up in your body. It can look like unexplained weight gain, swelling in your legs or ankles, or trouble breathing. If you notice these symptoms, contact your healthcare team. A healthcare professional may prescribe a medication called a diuretic to help you get rid of the extra fluid. They may also recommend taking a break from Vanrafia (atrasentan) to help reduce swelling.
In studies, some people with diabetic kidney disease had a lower sperm count while taking Vanrafia (atrasentan). Sperm count went back to normal within 3 months after stopping the medication.
This effect hasn’t been studied in people with IgAN. But it’s important to know that low sperm counts might be possible while taking Vanrafia (atrasentan). This might make it less likely that you’ll be able to father a child. Talk to your healthcare team if you’re worried about this risk.
The typical dose is 0.75 mg by mouth once daily with or without food.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Vanrafia (atrasentan) will not be safe for you to take.